Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10
2023 · Pharmacological Research · 54 citations
https://doi.org/10.1016/j.phrs.2023.106988
Z
Zi-Han Ye
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
104
Citations
4
h-index
3
i10-index
Zi-Han Ye is an academic researcher from University of Macau. The author has contributed to research in topics: Phagocytosis and Immune Regulation & Immune cells in cancer & Nanoparticle-Based Drug Delivery. The author has an h-index of 4, co-authored 5 publications.
Papers by this author
worksBuilding on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
2022 · Acta Pharmaceutica Sinica B · 34 citations
https://doi.org/10.1016/j.apsb.2022.12.016
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases
2024 · Acta Pharmaceutica Sinica B · 4 citations
https://doi.org/10.1016/j.apsb.2024.11.018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat